Evidence map›Paper›PMID 22480142›Full record

ArticleJournal of the American Chemical Society2012

Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

Mary A Rodgers, Valerie A Villareal, Esperance A Schaefer, Lee F Peng, Kathleen E Corey, Raymond T Chung, Priscilla L Yang

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Targeting of the hydrophobic metabolome by pathogens.Traffic (Copenhagen, Denmark) · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mary A RodgersDepartment of Microbiology and Immunobiology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.
Valerie A Villareal
Esperance A Schaefer
Lee F Peng
Kathleen E Corey
Raymond T Chung
Priscilla L Yang
Harvard University · USMassachusetts General Hospital · US

Funding

Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG, GEORG Michael LAUER · 2009 to 2026
$48.1M
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease ProgressionR01DK098079 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, RAYMOND T · 2013 to 2016
$2.7M
Validation of Src kinases as Anti-Dengue Viral TargetsR01AI076442 · NIAID · HARVARD MEDICAL SCHOOL · PI YANG, PRISCILLA LI-NING · 2008 to 2012
$2.1M
HIV-Hepatitis C Virus Interactions and PathogenesisR01AI069939 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, RAYMOND T · 2006 to 2010
$1.9M
Patient-Oriented Research on Hepatitis in Special PopulationsK24DK078772 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHUNG, RAYMOND T · 2007 to 2016
$1.6M
The Relationship of Host Cholesterol Biosynthesis to Chronic HCV InfectionK08DK088951 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI PENG, LEE F · 2010 to 2014
$795k
Directed Evolution of a Murine Model of Hepatitis C Virus ReplicationR21AI068999 · NIAID · HARVARD MEDICAL SCHOOL · PI YANG, PRISCILLA LI-NING · 2009 to 2010
$466k
NIAID NIH HHS AI069939NIAID NIH HHS AI082630NIAID NIH HHS R01 AI069939NIAID NIH HHS R01 AI076442NIAID NIH HHS R01AI076442NIAID NIH HHS R21 AI068999NIAID NIH HHS R21AI068999NIAID NIH HHS U19 AI082630NIDDK NIH HHS 1K08DK088951-01NIDDK NIH HHS K08 DK088951NIDDK NIH HHS K24 DK078772NIDDK NIH HHS R01 DK098079
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection has been clinically associated with serum lipid abnormalities, yet our understanding of the effects of HCV on host lipid metabolism and conversely the function of individual lipids in HCV replication remains incomplete. Using liquid chromatography-mass spectrometry metabolite profiling of the HCV JFH1 cell culture infection model, we identified a significant steady-state accumulation of desmosterol, an immediate precursor to cholesterol. Pharmacological inhibition or RNAi-mediated depletion of DHCR7 significantly reduced steady-state HCV protein expression and viral genomic RNA. Moreover, this effect was reversed when cultures were supplemented with exogenous desmosterol. Together, these observations suggest an intimate connection between HCV replication and desmosterol homeostasis and that the enzymes responsible for synthesis of desmosterol may be novel targets for antiviral design.

Indexed as

Antiviral AgentsCells, CulturedDesmosterolHepacivirusHepatitis CHumansLipid MetabolismVirus ReplicationAntiviral AgentsDesmosterol

Identifiers

PMID22480142
PMCPMC3375380
OpenAlexW2009098313

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.